Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ISRCTN |
Last refreshed on:
|
19 February 2018 |
Main ID: |
ISRCTN52284448 |
Date of registration:
|
14/04/2016 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Parkinson's disease, exercise and cognitive training
|
Scientific title:
|
Effects of the combination of physical exercise and cognitive training on cognitive functions in patients with Parkinson's disease |
Date of first enrolment:
|
01/06/2016 |
Target sample size:
|
60 |
Recruitment status: |
Completed |
URL:
|
http://isrctn.com/ISRCTN52284448 |
Study type:
|
Interventional |
Study design:
|
Single-centre randomised parallel trial (Quality of life)
|
Phase:
|
|
|
Countries of recruitment
|
Spain
| | | | | | | |
Contacts
|
Name:
|
|
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
|
|
Name:
|
Miguel
Fernández del Olmo |
Address:
|
Departamento de Educación Física e Deportiva
Facultade de Ciencias do Deporte e a Educación Física (INEF Galicia)
Avd. Ernesto Che Guevara 121, Pazos-Liáns
15179
A Coruña
Spain |
Telephone:
|
+34 981167000 |
Email:
|
mafo@udc.es |
Affiliation:
|
|
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: 1. Aged 40–80 years 2. Diagnosed with PD according to UK PD Society Brain Bank Criteria.26 3. Disease severity of Hoehn and Yahr (H&Y) stages I–III
Exclusion criteria: 1. Significant cognitive impairment (Mini-Mental State Examination < 23) 2. Below average premorbid intelligence (vocabulary subtest, Wechsler Adult Intelligence Scale-III [WAIS-III] typical score < 40) 3. Major depression (GDS-15 > 10) 4. Severe auditory or visual deficits 5. Another psychiatric/neurological condition
Age minimum:
Age maximum:
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Parkinson's disease Nervous System Diseases Parkinson's disease
|
Intervention(s)
|
Patients will be allocated randomly in two groups, a group of multimodal intervention (physical exercise + cognitive training) and a group of unimodal intervention (cognitive training).
Group 1: Participants complete cognitive training alone. This involves completing computer tasks, individualized for the cognitive capacity, using the software SmartBrain (http://www.smartbrain.net/). Participants complete three sessions a weeks for eight weeks, lasting for around 64 minutes per session.
Group 2: Participants complete the cognitive training whiles walking on a treadmill, by using touch screen technology. Participants complete three sessions a weeks for eight weeks, lasting for around 64 minutes per session.
Two weeks before and after the training programs, clinical, motor, neuropsychogical and neurophysiological evaluations will be conducted. A two month follow up will also be performed.
|
Primary Outcome(s)
|
1. Cognitive performance is measured using CDS (Cognitive Difficulties Scale), WAIS-III (Wechsler Adult Intelligence Scale-III), Digital Span Forward and backwards, Trail Making Test A and B, Stroop Test, Corsi Block, Verbal Fluency (FAS), Tower of London and Wilcoxin Card Sorting Test at 2 month before intervention, 2 weeks before intervention (baseline), 2 weeks post-intervention and two months post-intervention (follow-up) 2. Motor performance is measured using walk at comfortable speed, Time Up & Go and walk with dual-task at 2 month before intervention, 2 weeks before intervention (baseline), 2 weeks post-intervention and two months post-intervention (follow-up) 3. Quality of life is measured using ADLS (Activities of Dayly Living Scale), QOLS (Quality Of Life Scale) and IPAQ (International Physical Activity Questionnaire) at 2 month before intervention, 2 weeks before intervention (baseline), 2 weeks post-intervention and two months post-intervention (follow-up)
|
Secondary Outcome(s)
|
1. Functional connectivity is measured using evoked related potentials at 2 weeks before intervention (baseline) and 2 weeks post-intervention 2. White matter is measured using diffusion tensor imaging at 2 weeks before intervention (baseline) and 2 weeks post-intervention
|
Secondary ID(s)
|
DEP2014-53896-R
|
Source(s) of Monetary Support
|
Ministerio de Economía y Competitividad
|
Ethics review
|
Status:
Approval date:
Contact:
Ethics committee of University of A Coruña, 30/12/2015, ref: 20/2014
|
Results
|
Results available:
|
Yes |
Date Posted:
|
|
Date Completed:
|
15/01/2018 |
URL:
|
|
|
|